The Department of Pathology is honored to announce the promotion and tenure of five of our esteemed faculty colleagues for 2020, effective October 1, 2020:
Shuko Harada, M.D., Genomic Diagnostics & Bioinformatics -- Promotion to Professor with Award of Tenure
Dr. Harada is the Section head of the Molecular Diagnostics Section and former Interim Director of the Division of Genomic Diagnostics & Bioinformatics. She has particular interests in precision medicine in oncology and pharmacogenomics, and is a member of the Precision Medicine Institute and the O’Neal Comprehensive Cancer Center.
Sooryanarayana Varambally, Ph.D.,Molecular & Cellular Pathology -- Promotion to Professor
Dr. Varambally’s research focus is on understanding the molecular basis of cancer using integrative genomic, epigenetic and proteomic approach. He is a scientist with the O’Neal Comprehensive Cancer Center. He is a cofounder of the UALCAN integrated data-mining platform for cancer data.
Douglas Hurst, Ph.D., Molecular & Cellular Pathology -- Promotion to Associate Professor.
Dr. Hurst is a cancer researcher and associate scientist with the O’Neal Comprehensive Cancer Center and the Center for Clinical and Translational Science (CCTS). He was recently awarded a Breast Cancer Research Foundation grant for the research project, “RANK Signaling Pathways in Breast Cancer Development” with co-PI Xu Feng, Ph.D.
Huma Fatima, MBBS,Associate Professor, Anatomic Pathology -- Award of Tenure
Dr. Huma Fatima is Section Head for Renal (Kidney) in Anatomic Pathology. She joined the Department of Pathology at the University of Alabama at Birmingham in 2011, following being certified by the Anatomic Board of Pathology, Inc. In Anatomic Pathology and Clinical Pathology with added qualification in Cytopathology.
Adam Wende, Ph.D., Associate Professor, Molecular & Cellular Pathology -- Award of Tenure
Dr. Wende is a researcher and Scientist with the O’Neal Comprehensive Cancer Center, Center for AIDS Research, and Minority Health & Research Center; and associate scientist with the Comprehensive Diabetes Center, Center for Exercise Medicine, and Comprehensive Cardiovascular Center. Since 2000, Dr. Wende has explored the regulation of metabolism and mitochondrial function with a specific focus on glucose utilization in heart and muscle. He and Dr. John Chatham recently secured an R21 award to study how O-GlcNAc regulates function of a healthy heart.
Congratulations to our colleagues on their hard work and dedication to the UAB Department of Pathology.